UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cross-talk between Notch and the Estrogen Receptor in Breast Cancer Suggests Novel Therapeutic Approaches

Cancer research (Chicago, Ill.), 2008-07, Vol.68 (13), p.5226-5235

2008

Volltextzugriff (PDF)

The effect of an exopolysaccharide probiotic molecule from Bacillus subtilis on breast cancer cells

Frontiers in oncology, 2023, Vol.13, p.1292635-1292635

2023

Volltextzugriff (PDF)

Preclinical study of a Kv11.1 potassium channel activator as antineoplastic approach for breast cancer

Oncotarget, 2018-01, Vol.9 (3), p.3321-3337

2018

Volltextzugriff (PDF)

Abstract LB230: Critical role for DAXX in triple negative breast cancer

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (8_Supplement), p.LB230-LB230

2023

Volltextzugriff (PDF)

Enhancement of Proton Transfer in Ion Channels by Membrane Phosphate Headgroups

The journal of physical chemistry. B, 2009-05, Vol.113 (19), p.6725-6731

2009

Volltextzugriff (PDF)

Proton Transfer in Water Wires in Proteins: Modulation by Local Constraint and Polarity in Gramicidin A Channels

Biophysical journal, 2007-09, Vol.93 (5), p.1571-1579

2007

Volltextzugriff (PDF)

Abstract PO4-27-12: Increasing DAXX as a Novel Approach to Inhibit Breast Cancer Stem Cells and Estrogen Receptor-positive Tumor Recurrence

Cancer research (Chicago, Ill.), 2024-05, Vol.84 (9_Supplement), p.PO4-27-12-PO4-27-12

2024

Volltextzugriff (PDF)

Notch-1-PTEN-ERK1/2 signaling axis promotes HER2+ breast cancer cell proliferation and stem cell survival

Oncogene, 2018-08, Vol.37 (33), p.4489-4504

2018

Volltextzugriff (PDF)

Abstract P3-05-03: KMT2D as a novel therapeutic target for HER2+ breast cancers

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P3-P3-05-03

2022

Volltextzugriff (PDF)

Abstract P1-08-22: The role of DAXX as a critical growth regulator of triple negative breast cancer

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P1-P1-08-22

2022

Volltextzugriff (PDF)

Abstract 5845: Roles for MLL2/ KMT2D or MLL3/ KMT2C in HER+ breast cancer stem cells

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.5845-5845

2018

Volltextzugriff (PDF)

DAXX Suppresses Tumor-Initiating Cells in Estrogen Receptor-Positive Breast Cancer Following Endocrine Therapy

Cancer research (Chicago, Ill.), 2019-10, Vol.79 (19), p.4965-4977

2019

Volltextzugriff (PDF)

Abstract 1859: Elucidating the role of KMT2D as a novel therapeutic target for resistant HER2+ breast cancer

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.1859-1859

2020

Volltextzugriff (PDF)

Abstract P3-11-01: Increasing DAXX Expression in ER+ Breast Cancer Cells to Overcome Endocrine Therapy Resistance

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.P3-P3-11-01

2023

Volltextzugriff (PDF)

Inhibition of HER2 Increases JAGGED1-dependent Breast Cancer Stem Cells: Role for Membrane JAGGED1

Clinical cancer research, 2018-09, Vol.24 (18), p.4566-4578

2018

Volltextzugriff (PDF)

Abstract 1823: Novel regulation of Jagged1 by ErbB2 in breast cancer: implications for anti-ErbB2 therapy

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.1823-1823

2014

Volltextzugriff (PDF)

Abstract 1831: PKCδ as a novel target for HER2-positive, trastuzumab resistant breast cancer

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.1831-1831

2018

Volltextzugriff (PDF)

Abstract 4769: Targeting HER2 enriches Jagged1 high cancer stem cells in breast cancer

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.4769-4769

2017

Volltextzugriff (PDF)

Small Ubiquitin-like Modifier Modification of Arrestin-3 Regulates Receptor Trafficking

The Journal of biological chemistry, 2011-02, Vol.286 (5), p.3884-3893

2011

Volltextzugriff (PDF)

PKCα Attenuates Jagged-1-Mediated Notch Signaling in ErbB-2-Positive Breast Cancer to Reverse Trastuzumab Resistance

Clinical cancer research, 2016-01, Vol.22 (1), p.175-186

2016

Volltextzugriff (PDF)

DAXX-inducing phytoestrogens inhibit ER+ tumor initiating cells and delay tumor development

NPJ breast cancer, 2020-08, Vol.6 (1), p.37-37, Article 37

2020

Volltextzugriff (PDF)

DAXX-inducing phytoestrogens inhibit ER+ tumor initiating cells and delay tumor development

NPJ breast cancer, 2020-08, Vol.6 (1), p.37

2020

Volltextzugriff (PDF)

Abstract LB-121: DAXX is a novel Notch-1 gene target and biomarker of GSI-sensitivity in ER+ breast cancer

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.LB-121-LB-121

2016

Volltextzugriff (PDF)

A Faculty Development Program for Nurse Educators Learning to Teach Online

TechTrends, 2010-11, Vol.54 (6), p.20-28

2010

Volltextzugriff (PDF)

Cellular backpacks for macrophage immunotherapy

Science advances, 2020-05, Vol.6 (18), p.eaaz6579

2020

Volltextzugriff (PDF)

1 – 25 von 124

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(121)
Mit Volltextzugriff
(115)

Publikationsform

Artikel
(123)
Bücher
(1)

Sprache

Englisch
(124)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cross-talk between Notch and the Estrogen Receptor in Breast Cancer Suggests Novel Therapeutic Approaches

The effect of an exopolysaccharide probiotic molecule from Bacillus subtilis on breast cancer cells

Preclinical study of a Kv11.1 potassium channel activator as antineoplastic approach for breast cancer

Abstract LB230: Critical role for DAXX in triple negative breast cancer

Enhancement of Proton Transfer in Ion Channels by Membrane Phosphate Headgroups

Proton Transfer in Water Wires in Proteins: Modulation by Local Constraint and Polarity in Gramicidin A Channels

Abstract PO4-27-12: Increasing DAXX as a Novel Approach to Inhibit Breast Cancer Stem Cells and Estrogen Receptor-positive Tumor Recurrence

Notch-1-PTEN-ERK1/2 signaling axis promotes HER2+ breast cancer cell proliferation and stem cell survival

Abstract P3-05-03: KMT2D as a novel therapeutic target for HER2+ breast cancers

Abstract P1-08-22: The role of DAXX as a critical growth regulator of triple negative breast cancer

Abstract 5845: Roles for MLL2/ KMT2D or MLL3/ KMT2C in HER+ breast cancer stem cells

DAXX Suppresses Tumor-Initiating Cells in Estrogen Receptor-Positive Breast Cancer Following Endocrine Therapy

Abstract 1859: Elucidating the role of KMT2D as a novel therapeutic target for resistant HER2+ breast cancer

Abstract P3-11-01: Increasing DAXX Expression in ER+ Breast Cancer Cells to Overcome Endocrine Therapy Resistance

Inhibition of HER2 Increases JAGGED1-dependent Breast Cancer Stem Cells: Role for Membrane JAGGED1

Abstract 1823: Novel regulation of Jagged1 by ErbB2 in breast cancer: implications for anti-ErbB2 therapy

Abstract 1831: PKCδ as a novel target for HER2-positive, trastuzumab resistant breast cancer

Abstract 4769: Targeting HER2 enriches Jagged1 high cancer stem cells in breast cancer

Small Ubiquitin-like Modifier Modification of Arrestin-3 Regulates Receptor Trafficking

PKCα Attenuates Jagged-1-Mediated Notch Signaling in ErbB-2-Positive Breast Cancer to Reverse Trastuzumab Resistance

DAXX-inducing phytoestrogens inhibit ER+ tumor initiating cells and delay tumor development

DAXX-inducing phytoestrogens inhibit ER+ tumor initiating cells and delay tumor development

Abstract LB-121: DAXX is a novel Notch-1 gene target and biomarker of GSI-sensitivity in ER+ breast cancer

A Faculty Development Program for Nurse Educators Learning to Teach Online

Cellular backpacks for macrophage immunotherapy

Suchergebnisse filtern